Mycophenolic acid is effective for systemic treatment of psoriasis. However
, there is no report about its topical use in this cutaneous disorder so fa
r. We undertook a randomized, placebo-controlled, within subject comparison
of mycophenolic acid 1% incorporated in an ointment base and the correspon
ding vehicle alone (placebo) using the psoriasis plaque test in 7 patients
with plaque-type psoriasis over a period of 3 weeks. Scoring of erythema an
d induration was performed 3 times weekly. After 3 weeks of occlusive treat
ment there was a reduction of the sum score for erythema and induration in
the mycophenolic acid-treated sites of 23% and of 5.7% in the vehicle-treat
ed sites, which was not statistically significant. No adverse advents were
noted during the time of study. We conclude that mycophenolic acid is ineff
ective when applied topically in psoriasis even under occlusion.